Integrated Electroporated‐Lysis Electrochemical Platform Enables Sensitive and Rapid EV Protein and miRNA Profiling Based on Multiplex‐Responsive CRISPR/Cas12a
Small · 2026-03 · 22 (13)
DOI: 10.1002/smll.202513331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 05.01.2026. Verfasst von Rui Fan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Researc…. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles, CRISPR-Cas Systems, Electrochemical Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guang Dong Basic and Applied Basic Research Foundation of China.
Abstract (Originalsprache)
Proteins and miRNAs in extracellular vesicles (EVs) have emerged as crucial biomarkers for tumor diagnosis. While CRISPR/Cas12a‐based platforms have shown great promise in nucleic acid and protein detection, their susceptibility to off‐target activation and structural instability remains a significant limitation. Here, we have developed an electroporation‐lysis electrochemical platform integrated with DNA cube‐cage‐locked CRISPR/Cas12a (DC‐Cas12a), termed EL‐DC‐Cas12a. This platform utilizes an electric field to rapidly lyse EVs, releasing their internal proteins and miRNAs. These released molecules then activate the DC‐Cas12a system, thereby triggering the displacement of two distinct crRNA/Cas12a complexes that correspond to EV proteins and miRNAs, respectively. These complexes then specifically recognize and cleave electrochemical probes, generating quantifiable electrochemical signals that enable synchronous and accurate analysis of the two biomarkers. The integrated workflow for EV lysis and detection can be completed within 40 min, greatly simplifying the overall operation. The detection limits (LOD) of this platform for EV PD‐L1 protein and miR‐1246 were 5.44 × 10 4 particles/mL and 3.59 × 10 3 particles/mL, respectively. Moreover, by applying machine learning algorithms to analyze the EV‐associated proteins and miRNAs profiling, the platform demonstrated a diagnostic accuracy of 98.3% in distinguishing healthy donors from early‐stage GC patients, and 99% in differentiating early‐stage from advanced‐stage GC patients in a clinical gastric cancer cohort. Therefore, the proposed platform offers a promising strategy for multiplexed detection of EV biomarkers and precise discrimination of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Lab…
- School of Medical Technology, Guangdong Medical University, Dongguan, P. R. China.
- School of Engineering Medicine, Beihang University, Beijing, P. R. China.
- Qingdao Research Institute, Beihang University, Qingdao, P. R. China.
- Center for Clinical Laboratory Diagnosis and Research, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, P. R. China.
- Key Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi of Guangxi Higher Education Institutions, Affiliated Hospital of Youjiang Medical University for Nationalities, B…
ORCID-Profile: Ye Zhang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guang Dong Basic and Applied Basic Research Foundation of China
- Shenzhen Science and Technology Innovation Committee
- Southern Medical University
- China Postdoctoral Science Foundation
- National Science Fund for Distinguished Young Scholars
- National Key Research and Development Program of China
Zitieren
APA
Fan, R., Tong, Y., Luo, S., He, Y., Yang, C., Li, W., Liu, J., Pan, J., Zhu, Y., Zhang, X., Zhu, J., Zhu, Y., Guo, Y., Li, L., Situ, B., Yan, X., Ma, W., Chang, L., & Zhang, Y. (2026). Integrated Electroporated‐Lysis Electrochemical Platform Enables Sensitive and Rapid EV Protein and miRNA Profiling Based on Multiplex‐Responsive CRISPR/Cas12a. Small, 22(13). https://doi.org/10.1002/smll.202513331
Vancouver
Fan R, Tong Y, Luo S, He Y, Yang C, Li W, et al. Integrated Electroporated‐Lysis Electrochemical Platform Enables Sensitive and Rapid EV Protein and miRNA Profiling Based on Multiplex‐Responsive CRISPR/Cas12a. Small. 2026;22(13). doi:10.1002/smll.202513331
BibTeX
@article{Fan2026,
author = {Fan, Rui and Tong, Yihang and Luo, Shihua and He, Yangfen and Yang, Chao and Li, Wenbin and Liu, Jieyan and Pan, Jiezhen and Zhu, Yiping and Zhang, Xiaohe and Zhu, Junfang and Zhu, Yitong and Guo, Yuhang and Li, Ling and Situ, Bo and Yan, Xiaohui and Ma, Wen and Chang, Lingqian and Zhang, Ye},
title = {Integrated Electroporated‐Lysis Electrochemical Platform Enables Sensitive and Rapid EV Protein and miRNA Profiling Based on Multiplex‐Responsive CRISPR/Cas12a},
journal = {Small},
year = {2026},
volume = {22},
number = {13},
doi = {10.1002/smll.202513331}
}
EUVIMED